Credit Suisse Ag Fibrogen Inc Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$2.49 - $20.59 $74,291 - $614,323
29,836 Added 39.12%
106,095 $286,000
Q1 2023

May 10, 2023
BUY
$15.95 - $25.18 $23,031 - $36,359
1,444 Added 1.93%
76,259 $1.42 Million
Q4 2022

Feb 13, 2023
SELL
$13.27 - $17.73 $27,415 - $36,630
-2,066 Reduced 2.69%
74,815 $1.2 Million
Q3 2022

Nov 10, 2022
BUY
$11.4 - $14.6 $149,351 - $191,274
13,101 Added 20.54%
76,881 $1 Million
Q2 2022

Aug 12, 2022
SELL
$7.94 - $12.96 $26,972 - $44,025
-3,397 Reduced 5.06%
63,780 $674,000
Q1 2022

May 16, 2022
BUY
$12.02 - $16.79 $80,065 - $111,838
6,661 Added 11.01%
67,177 $807,000
Q4 2021

Feb 14, 2022
SELL
$9.93 - $15.39 $89,111 - $138,109
-8,974 Reduced 12.91%
60,516 $854,000
Q3 2021

Nov 12, 2021
SELL
$10.18 - $26.64 $54,890 - $143,642
-5,392 Reduced 7.2%
69,490 $710,000
Q2 2021

Aug 16, 2021
SELL
$18.57 - $35.68 $159,850 - $307,133
-8,608 Reduced 10.31%
74,882 $1.99 Million
Q1 2021

May 14, 2021
SELL
$31.0 - $55.72 $2.31 Million - $4.16 Million
-74,666 Reduced 47.21%
83,490 $2.9 Million
Q4 2020

Feb 12, 2021
BUY
$37.09 - $48.97 $1.91 Million - $2.53 Million
51,624 Added 48.46%
158,156 $5.87 Million
Q3 2020

Nov 13, 2020
SELL
$40.47 - $45.5 $22.6 Million - $25.4 Million
-557,911 Reduced 83.97%
106,532 $4.38 Million
Q2 2020

Aug 12, 2020
BUY
$32.57 - $42.83 $3.78 Million - $4.97 Million
115,994 Added 21.15%
664,443 $26.9 Million
Q1 2020

May 13, 2020
SELL
$23.3 - $45.96 $1.41 Million - $2.77 Million
-60,373 Reduced 9.92%
548,449 $19.1 Million
Q4 2019

Feb 12, 2020
BUY
$34.58 - $48.06 $4.34 Million - $6.04 Million
125,608 Added 25.99%
608,822 $26.1 Million
Q3 2019

Nov 12, 2019
SELL
$36.98 - $48.45 $1.24 Million - $1.62 Million
-33,426 Reduced 6.47%
483,214 $17.9 Million
Q2 2019

Aug 14, 2019
BUY
$35.13 - $55.53 $238,743 - $377,381
6,796 Added 1.33%
516,640 $23.3 Million
Q1 2019

May 14, 2019
SELL
$42.83 - $59.91 $2.51 Million - $3.51 Million
-58,555 Reduced 10.3%
509,844 $27.7 Million
Q4 2018

Feb 13, 2019
SELL
$37.97 - $60.16 $610,747 - $967,673
-16,085 Reduced 2.75%
568,399 $26.3 Million
Q3 2018

Nov 13, 2018
SELL
$56.3 - $67.25 $4.88 Million - $5.83 Million
-86,757 Reduced 12.92%
584,484 $35.5 Million
Q2 2018

Aug 14, 2018
SELL
$44.9 - $64.95 $8.93 Million - $12.9 Million
-198,785 Reduced 22.85%
671,241 $42 Million
Q1 2018

May 15, 2018
BUY
$45.35 - $61.65 $35.9 Million - $48.8 Million
791,314 Added 1005.33%
870,026 $40.2 Million
Q4 2017

Feb 14, 2018
SELL
$41.95 - $60.1 $319,491 - $457,721
-7,616 Reduced 8.82%
78,712 $3.73 Million
Q3 2017

Nov 14, 2017
BUY
$33.4 - $53.9 $1 Million - $1.62 Million
30,043 Added 53.38%
86,328 $4.64 Million
Q2 2017

Aug 14, 2017
BUY
N/A
56,285
56,285 $1.82 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email